Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management
Abdulrahman Alwhaibi, Sary Alsanea, Bana Almadi, Jawza F. Alsabhan, Fahad D. Alosaimi
Abstract
Our work supports the recent attention towards mood issues as an adverse effect of ADT, and that greater awareness of this is warranted among clinicians. Clinical studies published regarding the use of antidepressants for other ADT associated adverse effects established the foundation that can be adopted to examine these therapies on ADT-induced depression.
Topics & Concepts
Androgen deprivation therapyProstate cancerMedicineDepression (economics)Observational studyInternal medicineOncologyCancerManagement of depressionPsychological interventionPsychiatryAlternative medicinePathologyEconomicsMacroeconomicsProstate Cancer Treatment and ResearchCancer survivorship and careBrain Metastases and Treatment